Use of JornayPM® to Treat ADHD in Pediatric Epilepsy
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Summary
This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.
Eligibility
- Age range
- 6–17 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Inclusion criteria: * Established diagnosis of epilepsy that requires treatment with anti-seizure medication. * No episodes of seizure clusters or status epilepticus within 30 days prior to entry into the study. * Diagnosis of ADHD with functional impairment. * Good general health as determined by medical history and physical examination, including stable vital signs. * Participant or legal caregiver capable of providing informed consent and fully capable of monitoring the subject's disease process and compliance with treatment. Exclusion Criteria: * • Previ…
Interventions
- Drugmethylphenidate hydrochloride (Jornay PM)
all participants will receive active treatment
Location
- Kennedy Krieger InstituteBaltimore, Maryland